Daniel Grosslight
Stock Analyst at Citigroup
(1.90)
# 3,091
Out of 4,886 analysts
96
Total ratings
38.98%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Initiates: Buy | $45 | $38.08 | +18.17% | 1 | Jun 25, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $157 → $170 | $164.45 | +3.37% | 6 | Jun 13, 2025 | |
| HIMS Hims & Hers Health | Maintains: Sell | $25 → $30 | $48.96 | -38.73% | 11 | May 6, 2025 | |
| HCAT Health Catalyst | Maintains: Buy | $7 → $6.5 | $4.04 | +60.89% | 9 | Apr 25, 2025 | |
| TDOC Teladoc Health | Maintains: Neutral | $11 → $8.75 | $8.51 | +2.82% | 11 | Apr 25, 2025 | |
| AGL agilon health | Upgrades: Buy | $3.25 → $5 | $2.39 | +109.21% | 5 | Apr 25, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $13 → $11 | $8.99 | +22.36% | 6 | Apr 17, 2025 | |
| EVH Evolent Health | Maintains: Buy | $21 → $18 | $11.78 | +52.80% | 4 | Jan 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $4.84 | +29.13% | 7 | Jan 10, 2025 | |
| MCK McKesson | Maintains: Buy | $713 → $677 | $724.11 | -6.51% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $28.41 | +23.20% | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $21.52 | +16.20% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $4.22 | +136.97% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $10.36 | -22.78% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $2.52 | -50.40% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $2.73 | +28.21% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.50 | +36.84% | 1 | Dec 11, 2019 |
Waystar Holding
Jun 25, 2025
Initiates: Buy
Price Target: $45
Current: $38.08
Upside: +18.17%
Cardinal Health
Jun 13, 2025
Maintains: Neutral
Price Target: $157 → $170
Current: $164.45
Upside: +3.37%
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $48.96
Upside: -38.73%
Health Catalyst
Apr 25, 2025
Maintains: Buy
Price Target: $7 → $6.5
Current: $4.04
Upside: +60.89%
Teladoc Health
Apr 25, 2025
Maintains: Neutral
Price Target: $11 → $8.75
Current: $8.51
Upside: +2.82%
agilon health
Apr 25, 2025
Upgrades: Buy
Price Target: $3.25 → $5
Current: $2.39
Upside: +109.21%
Owens & Minor
Apr 17, 2025
Maintains: Buy
Price Target: $13 → $11
Current: $8.99
Upside: +22.36%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $11.78
Upside: +52.80%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $4.84
Upside: +29.13%
McKesson
Jan 10, 2025
Maintains: Buy
Price Target: $713 → $677
Current: $724.11
Upside: -6.51%
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $28.41
Upside: +23.20%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $21.52
Upside: +16.20%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $4.22
Upside: +136.97%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $10.36
Upside: -22.78%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $2.52
Upside: -50.40%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $2.73
Upside: +28.21%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $9.50
Upside: +36.84%